Any feedback?
Please rate this page
(literature.php)
(0/150)

BRENDA support

Literature summary for 2.7.8.27 extracted from

  • Liu, J.; Huan, C.; Chakraborty, M.; Zhang, H.; Lu, D.; Kuo, M.S.; Cao, G.; Jiang, X.C.
    Macrophage sphingomyelin synthase 2 deficiency decreases atherosclerosis in mice (2009), Circ. Res., 105, 295-303.
    View publication on PubMedView publication on EuropePMC

Application

Application Comment Organism
medicine SMS2 is a potential therapeutic target for treatment of atherosclerosis Mus musculus

Natural Substrates/ Products (Substrates)

Natural Substrates Organism Comment (Nat. Sub.) Natural Products Comment (Nat. Pro.) Rev. Reac.
ceramide + phosphatidylcholine Mus musculus
-
sphingomyelin + 1,2-diacyl-sn-glycerol
-
?

Organism

Organism UniProt Comment Textmining
Mus musculus
-
-
-

Source Tissue

Source Tissue Comment Organism Textmining
macrophage
-
Mus musculus
-

Substrates and Products (Substrate)

Substrates Comment Substrates Organism Products Comment (Products) Rev. Reac.
ceramide + phosphatidylcholine
-
Mus musculus sphingomyelin + 1,2-diacyl-sn-glycerol
-
?

Synonyms

Synonyms Comment Organism
SMS2
-
Mus musculus
sphingomyelin synthase 2
-
Mus musculus

General Information

General Information Comment Organism
malfunction SMS2 deficiency causes significant induction of cholesterol efflux in vitro and in vivo, SMS2 deficiency in the macrophages reduces atherosclerosis in mice Mus musculus